SFEE Letter to the Government: Innovation Is Burdened - There Is a Lag in Attracting Clinical Studies - iefimerida.gr
5 Articles
5 Articles
On the occasion of the issuance of the recent Joint Ministerial Decision B1β,B2α,β/οικ.4086 on the Investment Clawback, the Association of Pharmaceutical Companies of Greece (SFEE) sent a letter to the Ministers of Economy and Finance, Kyriakos Pierrakakis, Health, Adonis Georgiadis, Development, Takis Theodorikakos, and State, Akis Skertsos. With its letter, SFEE highlights the Association's consistent positions on the great lag of our country …
In 2021, 50 million were absorbed for clinical studies out of a total of 100 million, and in 2023 it was reduced to 5.5 million out of a total of 125 million.
The Association in a letter to top ministers calls for a coherent and long-term strategy to attract more clinical trials to Greece, highlighting the benefits for patients, the health system and the national economy. The need to redesign the incentives for attracting clinical trials in Greece is raised by the Association of Pharmaceutical Enterprises of Greece (SFEE), calling the investment clawback a “missed opportunity” for the health system an…
NewsBomb
CNN Greece"A missed opportunity for the health system but mainly for patients" says SFEE about clinical research in relation to investment clawback
Coverage Details
Bias Distribution
- 100% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
